Skip to main content

Research Repository

Advanced Search

Outputs (163)

Perceptions of risk in people with inflammatory arthritis during the COVID-19 pandemic (2022)
Journal Article
Ryan, S., Campbell, P., Paskins, Z., Manning, F., Rule, K., Hassell, A., Brooks, M., & Hider, S. (2022). Perceptions of risk in people with inflammatory arthritis during the COVID-19 pandemic. Rheumatology Advances in Practice, 6(2), Article rkac050. https://doi.org/10.1093/rap/rkac050

Objective
People with inflammatory arthritis have an increased incidence of serious illness and mortality, placing them at risk of poor outcomes from coronavirus disease 2019 (COVID-19). This study explored patients’ perceptions of risk from COVID-1... Read More about Perceptions of risk in people with inflammatory arthritis during the COVID-19 pandemic.

Gait rehabilitation for foot and ankle impairments in early rheumatoid arthritis: a feasibility study of a new gait rehabilitation programme (GREAT Strides) (2022)
Journal Article
Hendry, G. J., Bearne, L., Foster, N. E., Godfrey, E., Hider, S., Jolly, L., Mason, H., McConnachie, A., McInnes, I. B., Patience, A., Sackley, C., Sekhon, M., Stanley, B., van der Leeden, M., Williams, A. E., Woodburn, J., & Steultjens, M. P. M. (2022). Gait rehabilitation for foot and ankle impairments in early rheumatoid arthritis: a feasibility study of a new gait rehabilitation programme (GREAT Strides). Pilot and Feasibility Studies, 8(1), Article ARTN 115. https://doi.org/10.1186/s40814-022-01061-9

Background: Foot impairments in early rheumatoid arthritis are common and lead to progressive deterioration of lower limb function. A gait rehabilitation programme underpinned by psychological techniques to improve adherence, may preserve gait and lo... Read More about Gait rehabilitation for foot and ankle impairments in early rheumatoid arthritis: a feasibility study of a new gait rehabilitation programme (GREAT Strides).

Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study (2022)
Journal Article
Muller, S., Hider, S. L., Sokhal, B. S., Lawton, S. A., Helliwell, T., & Mallen, C. D. (2022). Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study. Rheumatology Advances in Practice, 6(2), Article rkac034. https://doi.org/10.1093/rap/rkac034

Objectives PMR is a common inflammatory condition in older adults, characterized by bilateral hip and shoulder pain and stiffness. Reducing oral glucocorticoids, classically used for <= 2 years, are the mainstay of treatment. This study considers the...

P064 Impact of COVID-19 on physical and mental health of people with inflammatory conditions: the ICEPAC survey (2022)
Journal Article
Roddy, Hider, Muller, & Paskins. (2022). P064 Impact of COVID-19 on physical and mental health of people with inflammatory conditions: the ICEPAC survey. Rheumatology, https://doi.org/10.1093/rheumatology/keac133.063

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background/Aims</jats:title> <jats:p>Concerns about the risk of COVID-19 infection led to guidelines advocating shielding for many people with inflammatory conditions. We aimed to assess the im... Read More about P064 Impact of COVID-19 on physical and mental health of people with inflammatory conditions: the ICEPAC survey.

P091 Who do we risk leaving behind? A survey of digital access and e-health literacy in people with inflammatory conditions (2022)
Journal Article
Roddy, Paskins, Hider, & Muller. (2022). P091 Who do we risk leaving behind? A survey of digital access and e-health literacy in people with inflammatory conditions. Rheumatology, https://doi.org/10.1093/rheumatology/keac133.090

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background/Aims</jats:title> <jats:p>The COVID-19 pandemic led to an overnight shift in healthcare delivery and rapid uptake of digital technology. Such approaches risk digital exclusion for pe... Read More about P091 Who do we risk leaving behind? A survey of digital access and e-health literacy in people with inflammatory conditions.

P183 Establishing the epidemiology of rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis in England using primary care electronic health record data (2022)
Presentation / Conference Contribution
Scott, I. C., Whittle, R., Bailey, J., Twohig, H., Hider, S., Mallen, C., Muller, S., & Jordan, K. P183 Establishing the epidemiology of rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis in England using primary care electronic health record data

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background/Aims</jats:title> <jats:p>The substantial personal and socioeconomic costs associated with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (SpA) mak... Read More about P183 Establishing the epidemiology of rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis in England using primary care electronic health record data.

Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort Study (2021)
Journal Article
Paskins, Z., Sokhal, B. S., Hider, S. L., Mallen, C. D., & Muller, S. (2021). Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort Study. Rheumatology Advances in Practice, Article rkab094. https://doi.org/10.1093/rap/rkab094

OBJECTIVES: PMR is a common indication for long-term glucocorticoid treatment, leading to an increased risk of osteoporosis and fragility fractures. Guidelines recommend calcium and vitamin D for all patients, in addition to anti-resorptive agents fo... Read More about Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort Study.

What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study (2021)
Journal Article
Weddell, J., Hider, S., Mallen, C., & Muller, S. (2022). What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study. Rheumatology International, 285-290. https://doi.org/10.1007/s00296-021-05036-6

Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are associated with significant adverse effects and many patients remain on high doses for a number of years. Little is known about the use of other, non-pharmacologi... Read More about What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study.

Diagnosis and management of rheumatoid arthritis (2021)
Journal Article
Weddell, J., & Hider, S. (2021). Diagnosis and management of rheumatoid arthritis. Prescriber, 32(10), 15-20. https://doi.org/10.1002/psb.1945

Rheumatoid arthritis (RA) is commonly encountered in primary care, and prompt identification and referral is vital to ensure timely treatment with disease‐modifying antirheumatic drugs (DMARDs) and better long‐term outcomes. This article discusses id... Read More about Diagnosis and management of rheumatoid arthritis.